Bernhard Zimmermann
Principal investigator, leads 149 MEDICAL INC.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$1.8MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 10, 2022 | NIH | STTR Phase II Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature Infants | $82K | 149 MEDICAL INC |
| Jun 15, 2021 | NIH | STTR Phase II Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature Infants | $542K | 149 MEDICAL INC |
| Jun 1, 2021 | NIH | STTR Phase II Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants | $999K | 149 MEDICAL INC with BRIGHAM AND WOMEN'S HOSPITAL |
| Sep 16, 2019 | NIH | STTR Phase II Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants | $150K | 149 MEDICAL INC |
Peer ranks
Federal funding#1,351
Awards as PI#643
Patents#505
Companies
- 149 MEDICAL INCLeads (SEC Form D) · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.